îæ€çŽ¢
îæ€çŽ¢
î
Drugs Made In America Acquisition Corp
DMAAUîãŠã©ãããªã¹ãã«è¿œå
10.690USD
0.0000.00%
çµå€Â 05/18, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
257.34Mæ䟡ç·é¡
--çŽè¿12ã¶æPER
î
詳现æ å ± Drugs Made In America Acquisition Corp äŒæ¥å
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corpã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãDMAAU
äŒç€ŸåDrugs Made In America Acquisition Corp
äžå Žæ¥Jan 28, 2025
æé«çµå¶è²¬ä»»è
ãCEOãStockwell (Lynn)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Unit
決ç®ææ«- -
æ¬ç€Ÿæåšå°1 East Broward Boulevard
éœåžFT LAUDERDALE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·33301
é»è©±çªå·19548703099
ãŠã§ããµã€ã
äŒæ¥ã³ãŒãDMAAU
äžå Žæ¥Jan 28, 2025
æé«çµå¶è²¬ä»»è
ãCEOãStockwell (Lynn)
Drugs Made In America Acquisition Corpã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Mon, Nov 17
æŽæ°æå»: Mon, Nov 17
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.30%
Clear Street Group Inc
0.39%
Clear Street LLC
0.20%
ä»ã®
80.24%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.30%
Clear Street Group Inc
0.39%
Clear Street LLC
0.20%
ä»ã®
80.24%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
17.88%
Investment Advisor
1.69%
Research Firm
0.20%
Investment Advisor/Hedge Fund
0.13%
ä»ã®
80.11%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
21
472.47K
2.02%
-2.92M
2025Q4
21
706.12K
14.40%
--
2025Q3
21
706.12K
14.40%
-280.00K
2025Q2
19
986.13K
14.72%
-2.41M
2025Q1
19
3.40M
0.80%
+3.21M
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Kryger Capital Limited
303.81K
1.3%
+3.81K
+1.27%
Dec 31, 2025
Clear Street Group Inc
91.22K
0.39%
+43.74K
+92.11%
Dec 31, 2025
Clear Street LLC
45.92K
0.2%
+40.07K
+685.09%
Jun 30, 2025
UBS Financial Services, Inc.
8.02K
0.03%
-10.36K
-56.37%
Dec 31, 2025
Heights Capital Management, Inc.
--
0%
-650.00K
-100.00%
Jun 30, 2025
Boothbay Fund Management, LLC
--
0%
-603.75K
-100.00%
Jun 30, 2025
Westchester Capital Management, LLC
--
0%
-500.00K
-100.00%
Jun 30, 2025
Verition Fund Management LLC
--
0%
-100.00K
-100.00%
Jun 30, 2025
Lazard Asset Management, L.L.C.
--
0%
-25.07K
-100.00%
Jun 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
0%
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
æ¯ç0%
SPAC and New Issue ETF
æ¯ç0%
RiverNorth Enhanced Pre-Merger SPAC ETF
æ¯ç0%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
